49.414210, 8.671640
German Cancer Research Center
Heidelberg, Germany
- Verified lead
- Prof. Dr. Michael Baumann
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chairman and Scientific Director
- 2026 technical specialization
- Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure
- Review cycle
- May 2026
- Full address
- Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
- Site coordinates
- 49.414210, 8.671640
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- DKFZ management disclosure.
- Editorial note
- National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.
Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure
Good scientific practice framework, National oncology research governance
National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.
German Cancer Research Center
Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure · Large national oncology-research centre
National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.
- Lead
- Prof. Dr. Michael Baumann (verified ↗)
- Address
- Im Neuenheimer Feld 280, 69120 Heidelberg, Germany (source ↗)
- Compliance
- GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Large national oncology-research centre
- Capabilities
- Cancer biology research · Translational oncology · Population and prevention science
- Founded
- 1964
- Headcount
- 1001-5000
- Company page (open ↗)
Prof. Dr. Michael Baumann
Chairman and Scientific Director
Official DKFZ contact page listing Im Neuenheimer Feld 280, Heidelberg.
Open sourceLarge national oncology-research centre
Heidelberg, Germany. Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure. Review completed on 15 Mar 2026.
Helmholtz and German federal oncology-research governance framework
Good scientific practice framework, National oncology research governance
Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure
National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.
DKFZ is a heavyweight Heidelberg anchor with formal scientific leadership, large-scale oncology infrastructure, and deep translational relevance for the cluster.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is German Cancer Research Center located?
- German Cancer Research Center operates from Im Neuenheimer Feld 280, 69120 Heidelberg, Germany, Heidelberg, Germany.
- Who runs German Cancer Research Center?
- German Cancer Research Center is led by Prof. Dr. Michael Baumann, Chairman and Scientific Director. Verified 15 Mar 2026.
- What does German Cancer Research Center do?
- National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity. Core capabilities: Cancer biology research, Translational oncology, Population and prevention science, National technology and data platforms.
Related technical briefs
Briefs that name Heidelberg as a covered market or city.
